Showing results (391-400 of 429) with videos related to
Sort By:
Pageof 43
Cureus|August 28, 2025
Colorectal Cancer Risk and Protective Factors Among People of African Descent: A Systematic Review and Meta-AnalysisCollins C Okeke, Angela Ojo, Onyinye E Ebiliekwe, et al.Nature Communications|August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|July 29, 2024
Establishing a paediatric critical care core quality measure set using a multistakeholder, consensus-driven processJessica A Schults, Karina R Charles, Johnny Millar, et al.Breast Cancer Research and Treatment|August 24, 2010
Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growthRobert S Tolhurst, Ross S Thomas, Fiona J Kyle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane studyJudith M Bliss, Lucy S Kilburn, Robert E Coleman, et al.Cancer Research|July 30, 2009
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activitySimak Ali, Dean A Heathcote, Sebastian H B Kroll, et al.Scientific Reports|February 17, 2026
Predicting multiphase flow and tracer transport for an underground chemical explosive testJohn P Ortiz, Dolan D Lucero, Esteban Rougier, et al.Cureus|April 28, 2025
A Systematic Review of the Impact and Outcome of Loneliness and Self-Isolation on Individuals Living With Cardiovascular DiseaseCollins C Okeke, Angela Ojo, Onyinye Ngige, et al.Nature Reviews. Clinical Oncology|December 6, 2018
A framework for the development of effective anti-metastatic agentsRobin L Anderson, Theo Balasas, Juliana Callaghan, et al.Carcinogenesis|March 22, 2013
SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancerMattaka Khongkow, Yolanda Olmos, Chun Gong, et al.Pageof 43